Stallion India Fluorochemicals: Co-Promoter's Share Sale Bolsters R-32 Project in Bhilwara

2 min read     Updated on 03 Nov 2025, 08:04 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Stallion India Fluorochemicals Limited's co-promoter has sold 16,20,987 shares, raising ₹45.74 crore to fund the R-32 production facility project in Bhilwara, Rajasthan. The entire proceeds will be infused into the company interest-free, demonstrating commitment to the project's timely commencement without diluting equity. Managing Director & CEO Shazad Rustomji emphasized the strategic importance of this move for the company's growth in the fluorochemicals sector.

23726091

*this image is generated using AI for illustrative purposes only.

Stallion India Fluorochemicals Limited (SIFL), a prominent player in the refrigerants and industrial gases sector, has announced a strategic move to strengthen its R-32 production facility project in Bhilwara, Rajasthan. The company's co-promoter has sold a portion of their shareholding to raise funds, which will be directly channeled into the development of this key manufacturing facility.

Strategic Share Sale

According to a press release dated November 3, 2025, the co-promoter of SIFL has sold 16,20,987 shares, raising approximately ₹45.74 crore. This move is aimed at ensuring the timely commencement of groundwork and construction activities for the R-32 project.

Commitment to Growth

In a noteworthy gesture of confidence in the company's future, the entire proceeds from the share sale will be infused into SIFL on an interest-free basis. This financial strategy underscores the promoter's long-term commitment to the company's growth trajectory while maintaining the current equity structure.

Management Perspective

Mr. Shazad Rustomji, Managing Director & CEO of Stallion India Fluorochemicals Limited, commented on the development:

"The decision to sell shares and infuse the entire amount into the company on an interest-free basis was to ensure that work on our R-32 manufacturing project at Bhilwara begins without any delay. This reflects my strong confidence in Stallion's strategic direction and my commitment to advancing our vision of self-reliance in fluorochemicals manufacturing."

Project Significance

The R-32 production facility in Bhilwara is a crucial component of SIFL's growth strategy. R-32 (difluoromethane) is an important refrigerant used in various air conditioning applications, known for its lower global warming potential compared to some other refrigerants.

Company Overview

Stallion India Fluorochemicals Limited, incorporated in 2002, has established itself as a specialized leader in the refrigerants and industrial gases sector over the past three decades. The company's operations span four strategic manufacturing facilities located in Khalapur, Ghiloth, Manesar, and Panvel, focusing on debulking, blending, and processing of gases.

SIFL serves a diverse range of industries, including air conditioning, refrigeration, fire-fighting, semiconductor manufacturing, pharmaceuticals, automotive, and glass production. The company's unique positioning in the market is attributed to its focus on gas blending, setting it apart from competitors who primarily manufacture base molecules.

Market Implications

This strategic move by SIFL's co-promoter demonstrates a strong vote of confidence in the company's future prospects. By ensuring the timely execution of the R-32 project without diluting equity, SIFL is positioning itself to capitalize on the growing demand for environmentally friendly refrigerants in the Indian market.

Investors and market watchers will likely keep a close eye on the progress of the Bhilwara facility and its potential impact on SIFL's market position in the coming months.

Historical Stock Returns for Stallion India Fluorochemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+3.69%+10.67%-20.76%-41.58%+64.90%-6.11%
Stallion India Fluorochemicals
View Company Insights
View All News
like16
dislike

Stallion India Fluorochemicals Reports 56% Revenue Surge in Q2, PAT Soars to ₹1,141.67 Lakh

2 min read     Updated on 16 Oct 2025, 12:37 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Stallion India Fluorochemicals Limited reported strong Q2 FY2025-26 results with revenue up 56% to ₹10,575.75 lakh and PAT surging 1,241% to ₹1,141.67 lakh. H1 FY2025-26 saw revenue increase 53% to ₹21,630.31 lakh and PAT rise 135% to ₹2,178.00 lakh. EBITDA margin improved to 14.91%. The company is expanding with new facilities in Andhra Pradesh and Maharashtra, targeting 30-35% CAGR over three years. Management expects profit margins to improve by 3-4% through strategic initiatives.

22144036

*this image is generated using AI for illustrative purposes only.

Stallion India Fluorochemicals Limited , a leading provider of refrigerant and industrial gases, has reported a robust financial performance for the second quarter of fiscal year 2025-26, with significant growth in both revenue and profitability.

Strong Revenue Growth

The company's total revenue for Q2 FY2025-26 stood at ₹10,575.75 lakh, representing a substantial year-over-year increase of 56% from ₹6,797.99 lakh in the corresponding quarter of the previous fiscal year. This impressive growth underscores the company's strong market position and increasing demand for its products.

Remarkable Profit Surge

Stallion India Fluorochemicals witnessed an extraordinary surge in its Profit After Tax (PAT) for Q2 FY2025-26, which rose to ₹1,141.67 lakh, marking a staggering 1,241% increase from ₹85.12 lakh in Q2 FY2024-25. This significant jump in profitability reflects the company's improved operational efficiency and strategic initiatives.

Half-Year Performance

For the first half of FY2025-26, the company's performance continued to be strong:

  • Total revenue reached ₹21,630.31 lakh, up 53% from ₹14,153.16 lakh in H1 FY2024-25.
  • PAT for H1 FY2025-26 stood at ₹2,178.00 lakh, a remarkable 135% increase from ₹926.69 lakh in the same period last year.

Operational Highlights

Stallion India Fluorochemicals currently operates four facilities across Maharashtra, Rajasthan, and Haryana. The company is in the process of expanding its operations with two new facilities:

  1. A 7,200 MT capacity plant in Andhra Pradesh
  2. A 1,200 MT semiconductor gas facility in Khalapur, Maharashtra

These expansions are expected to strengthen the company's market position and cater to growing demand in various sectors.

Financial Metrics

Metric Q2 FY2025-26 Q2 FY2024-25 YoY Change
EBITDA 1,576.77 235.77 568.77%
EBITDA Margin 14.91% 3.47% 11.44 pp
PAT Margin 10.80% 1.25% 9.55 pp

The company's EBITDA margin improved significantly to 14.91% in Q2 FY2025-26 from 3.47% in the same quarter last year, indicating enhanced operational efficiency.

Future Outlook

Stallion India Fluorochemicals is targeting a 30-35% CAGR growth over the next three years. The company expects its strategic initiatives, including backward integration and expansion into higher-value products like semiconductor gases, to improve profit margins by 3-4%.

Management Commentary

Shazad Rustomji, Managing Director & CEO of Stallion India Fluorochemicals, stated, "Our strong performance in Q2 and H1 FY2025-26 reflects the success of our strategic initiatives and the growing demand for our products. We are particularly excited about our expansion into specialty and semiconductor gas capabilities, which will position us at the forefront of India's emerging technology needs."

The company's focus on forward integration, coupled with plans for backward integration, is expected to create significant growth potential and support its ambition to emerge as an industry leader in the fluorochemicals sector.

As Stallion India Fluorochemicals continues to expand its product portfolio and manufacturing capabilities, it remains well-positioned to capitalize on the growing demand for refrigerants and industrial gases across various sectors in India.

Historical Stock Returns for Stallion India Fluorochemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+3.69%+10.67%-20.76%-41.58%+64.90%-6.11%
Stallion India Fluorochemicals
View Company Insights
View All News
like18
dislike

More News on Stallion India Fluorochemicals

1 Year Returns:+64.90%